4//SEC Filing
SQUINTO STEPHEN P 4
Accession 0001104659-22-063509
CIK 0001773427other
Filed
May 19, 8:00 PM ET
Accepted
May 20, 5:44 PM ET
Size
9.3 KB
Accession
0001104659-22-063509
Insider Transaction Report
Form 4
SQUINTO STEPHEN P
Director10% Owner
Transactions
- Award
Common Stock
2022-05-19+4,818→ 131,652 total - Award
Stock Option (Right to Buy)
2022-05-19+15,318→ 15,318 totalExercise: $35.42Exp: 2032-05-19→ Common Stock (15,318 underlying)
Holdings
- 6,186,307(indirect: See Footnote)
Common Stock
Footnotes (4)
- [F1]This transaction represents a grant of restricted stock units ("RSUs") pursuant to the terms of the Issuer's Amended and Restated Non-Employee Director Compensation Policy which provides for annual equity grants to the Issuer's non-employee directors on the date of the Issuer's annual meeting of stockholders. The RSUs shall vest in full on the earlier of (1) May 19, 2023 and (2) the next annual meeting of stockholders, subject to continued service to the Issuer by the Reporting Person.
- [F2]Shares held by OrbiMed Private Investments VI, LP ("OrbiMed VI"). OrbiMed Capital GP VI LLC ("GP VI") is the general partner of OrbiMed VI. OrbiMed Advisors, LLC ("Advisors") is the managing member of GP VI. By virtue of such relationship, GP VI and Advisors may be deemed to have voting and investment power with respect to the shares held by OrbiMed VI and as a result may be deemed to have beneficial ownership of such shares. The reporting person is an Executive Partner at Advisors. This report shall not be deemed an admission that the reporting person is a beneficial owner of such securities for the purpose of Section 16 of the Exchange Act, or for any other purpose.
- [F3]This transaction represents a grant of options pursuant to the terms of the Issuer's Amended and Restated Non-Employee Director Compensation Policy which provides for annual equity grants to the Issuer's non-employee directors on the date of the Issuer's annual meeting of stockholders.
- [F4]The options shall vest in full on the earlier of (1) May 19, 2023 and (2) the next annual meeting of stockholders, subject to continued service to the Issuer by the Reporting Person.
Documents
Issuer
SpringWorks Therapeutics, Inc.
CIK 0001773427
Entity typeother
Related Parties
1- filerCIK 0001231954
Filing Metadata
- Form type
- 4
- Filed
- May 19, 8:00 PM ET
- Accepted
- May 20, 5:44 PM ET
- Size
- 9.3 KB